Ryan Specialty (RYAN) Was Downgraded—So Why Are Investors Still Paying Attention?

With an upside potential of 35.74%, Ryan Specialty Holdings, Inc. (NYSE:RYAN) is among the 10 Best Insurance Stocks to Buy Following Q1 Earnings.

Ryan Specialty Holdings, Inc. (NYSE:RYAN) attracted mixed but noteworthy analyst attention on June 8 when Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to $35 from $42. The firm cited expectations for a prolonged period of commercial property and casualty insurance pricing moderation, which could make it more difficult for the company to achieve consensus forecasts for accelerating organic growth in future years. Despite the downgrade, Goldman acknowledged that Ryan Specialty remains a leading participant in the specialty insurance market, with concerns centered primarily on growth expectations rather than the quality of the underlying business.

Previously, on May 27, Keefe Bruyette raised its price target on Ryan Specialty Holdings, Inc. (NYSE:RYAN) to $44 from $42 while maintaining an Outperform rating. The firm viewed the company’s decision to increase its share repurchase authorization by $300 million as a strong signal of management’s confidence in its financial position, cash-generation capabilities, and long-term growth prospects. The expanded buyback program highlights Ryan Specialty’s ability to return capital to shareholders while continuing to invest in its business and strategic growth initiatives.

Founded in 2010 and headquartered in Chicago, Illinois, Ryan Specialty Holdings, Inc. (NYSE:RYAN) is an international specialty insurance organization that operates as a wholesale broker and managing underwriter. The company provides specialized distribution, underwriting, product development, and risk-management services for complex or difficult-to-place insurance risks.

READ NEXT: 10 Under-the-Radar AI Stocks to Buy in 2026 and Top 10 Stocks That Members of Congress Own.

Disclosure: None.  Follow Insider Monkey on Google News.